From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Vasopressin Adds No Benefit to Epinephrine in Cardiac Arrest

Defibrillation and chest compressions remain key to survival.

Animal studies and small human studies have provided preliminary evidence that adding vasopressin to the standard advanced cardiac life support (ACLS) drug regimen improves survival after cardiac arrest. However, this evidence had not been validated in a large, randomized, placebo-controlled trial.

In a multicenter study, researchers in France randomized 2894 patients with out-of-hospital cardiac arrest to receive epinephrine (1 mg) plus either placebo or vasopressin (40 IU) after three failed attempts at defibrillation. The assigned drug regimen was repeated after 3 minutes if spontaneous circulation was not restored, and open-label epinephrine was administered at the discretion of the treating physician if after another 3 minutes spontaneous circulation still was not restored.

The primary endpoint was survival to hospital admission (defined as admission of a patient with measurable blood pressure and palpable pulse to an intensive care unit). Secondary endpoints included survival to hospital discharge, neurologic status at discharge, and 1-year survival. Rates of the primary endpoint and all secondary endpoints did not differ between the vasopressin and control groups. Patients were significantly more likely to survive to hospital admission if their arrests were witnessed than if their arrests were unwitnessed. Patients also were more likely to survive to hospital admission if they received basic life support (BLS) within 8 minutes and ACLS within 12 minutes after arrest than if they received BLS and ACLS later.

Comment: In this large study with few protocol violations, the finding is unequivocally definitive: Vasopressin has no benefit in cardiac arrest. Early shock therapy and rapid chest compressions as specified in the current BLS protocols offer the best chance for survival.

J. Stephen Bohan, MD, MS, FACP, FACEP

Published in Journal Watch Emergency Medicine July 2, 2008

Citation(s):

Gueugniaud P-Y et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008 Jul 3; 359:21.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Other Perspectives

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.